Keele Cardiovascular Research Group,

Centre for Prognosis Research

Keele University Stoke-on-Trent, ST4 7QB

Department of Cardiology, Royal Stoke Hospital

University Hospital North Staffordshire


Professor Mamas A. Mamas

Director for the Centre for Prognosis Research, Institute of Primary Care and Health Sciences
Professor of Interventional Cardiology, Keele University and Honorary Consultant Cardiologist, Royal Stoke Hospital
Honorary Professor of Population Health, University of Manchester
Adjunct Professor of Research Jefferson University, Philadelphia, USA
Visiting Professor Case Western University, Heart & Vascular Center, MetroHealth Medical Center, USA



1997-2000 BM BCh Clinical Medicine, University of Oxford
1994-1997 DPhil (Physiological Sciences), University of Oxford. Funded by BHF Studentship
1993-1994 MA (Physiological Sciences) Class 2:1. University of Oxford
1991-1994 First BM Preclinical Medicine, St Annes College, University of Oxford


2015 FRCP London
2012 CCST Cardiology, Royal College of Physicians
2003 MRCP London

Academic Posts

2015-Current Professor of Cardiology, University of Keele
Honorary Consultant Interventional Cardiologist, Royal Stoke Hospital, Stoke-on-Trent
2012-2015 Senior Lecturer in Cardiology, University of Manchester
Honorary Consultant Interventional Cardiologist, Manchester Royal Infirmary, Manchester
2006-2012 Lecturer in Cardiology, University of Manchester
Specialist Registrar Cardiology, Northwest Deanery


• Clinical Director of the Centre for Prognosis Research at Keele University that was ranked as internationally excellent in the recent UK national Research Excellence Framework
• Lead a multidisciplinary centre of clinicians, data scientists and statisticians whose research interests focus around the use of routinely collected electronic healthcare data to inform the diagnosis, treatment and clinical outcomes of patients
• Responsible for the development and implementation of a clinical research strategy for the centre, and operational and line management of clinical staff
• I am senior clinical editor of TCTMD ( the world’s leading resource for interventional cardiovascular news and education, catering to an audience of clinicians and researchers. The site provides breaking news and in-depth features covering interventional cardiology and beyond, providing an in-depth coverage across the spectrum of cardiovascular disease research and practice.
• High volume practicing interventional cardiologist in the United Kingdom in one of the largest PCI centres in the UK (Royal Stoke Hospital). I have a special interest in intravascular imaging utilising OCT or IVUS in 100% of my cases. I have extensive experience of rotational atherectomy, laser, lithotripsy and complex LMS PCI.
• I am a course director of several international conferences including TCT Asia Pacific and Chip CTO india



• My focus is to deliver high-quality, cutting-edge big data cardiology research linking electronic health data from patients with cardiovascular disease to inform the diagnosis, treatment, and clinical outcomes of real-world patients with cardiovascular disease.
• Our work is cross thematic, with work around interventional cardiology, cardio-oncology and multimorbidity focusing around studying clinical outcomes, complications and assessment of treatment efficacy of interventions / medical treatments using real world data derived from the national electronic healthcare records of patients with cardiovascular disease, as well as prognostic modelling leading development of risk stratification tools used for national reporting.
• My group uses national audit data derived from the national cardiovascular societies at the National Institute of Cardiovascular Outcomes Research (NICOR;, data derived from primary care (Clinical Practice Research Datalink; as well as large datasets from the US such as from the Healthcare Cost and Utilization Project (HCUP), Centers for Disease Control and Prevention (CDC) and National Health and Nutrition Examination Survey (NHANES) to study outcomes in patients with cardiovascular diseases.
• I have published over 800 peer-reviewed papers in the highest impact international cardiovascular journals (h-index 83) using big data in populations with cardiovascular disease and our work has consistently attracted editorials from international leaders in the field and has received widespread media coverage.
• I was recently voted as one of the top 100 health pioneers in the UK by the #MadeAtUni campaign based on my work using Big Data and its implementation in patients with cardiovascular disease
• During the current COVID-19 crises I led a program of work analysing real-time CV data to provide information to the Scientific Advisory Group for Emergencies (SAGE) for the UK government and NHS England. A subsequent national report was published that my group led a number of the analyses contained within it:


• European Society of Cardiology EAPCI Board member
• European Society of Cardiology CardioOncology WG
• European Society of Cardiology eCardiology WG
• European Society of Cardiology Quality Standards Diabetes working group
• European Society of Cardiology TAVI database working group
• European Society of Cardiology ACS guidelines reviewer 2023
• SCAI position statement on PCI activity in non-surgical centres
• American Heart Association 2022 AHA/ACC Chest Pain-AMI Data Standards reviewer
• Society of Cardiac CT position statement cardio-oncology
• American Heart Association women in cardiology committee
• European Society of Cardiology ACS NSTEMI guidelines review co-ordinator 2020
• Senior Clinical Editor TCTMD


• British Cardiovascular Intervention Society council member and National Audit of PCI (NAPCI) lead
• CVD-COVID-UK consortium member HDRUK
• NIHR HTA interventional procedures panel (2017-2021)
• Heart Research UK Medical Review Panel
• National Institute of Cardiovascular Outcomes and Research (NICOR) Research Executive Group
• Cardiovascular theme lead Greater Manchester CLRN (2013-2015)
Clinical trial steering groups
• NIHR UK GRIS trial steering committee (
• NIHR Pirouette trial Data Safety and Monitoring Committee (
• NIHR ARREST trial. Trial Steering Committee (


2022 NIHR Biomedical Research Centre, Partenership between University Hospitals Birmingham, Birmingham University, Keele University £30.7 million (Co-applicant)
2022 NIHR SPCR FR 6 Cardiovascular safety of febuxostat £81,805
2022 NIHR ICA Pre-doctoral Clinical and Practitioner Academic Fellowship 302718 for Joseph Mayer (Principle supervisor)
2021 Wolfson foundation £330,000 KUGAR (Keele University GPU-accelerated Research) Computer cluster funding (co-investigator)
2020 Abbott Vascular. Clinical outcomes in complex PCI £131,008 (Principal Investigator)
2020 Terumo. PCI outcomes post discharge, towards a prognostic model to predict 30 day PCI outcomes (Principal Investigator) £199,474
2019 Oliver Bird Foundation. The impact of musculoskeletal conditions on outcomes of other illnesses: a linked electronic health record study. £350,144, Reference: OBF/43974
2019 British Heart Foundation. Cardiovascular prognosis in patients with undiagnosed chest pain: an electronic health record cohort study. £201,686 (Co Investigator)
2019 Toward Holistic Approaches to Clinical Prediction of Multi-Morbidity: A Dynamic Synergy of Inter-Connected Risk Models. £501,249, MRC Reference: MR/T025085/1
2019 Heart Research UK. Development and validation of a risk stratification tool for patients with acute myocardial infarction (AMI) in UK primary care. £147,816 (Principal Investigator)
2018 Medtronic. A national cohort study of clinical outcomes in patients receiving implantable cardiac devices using Big Data. £234,000 (Principal Investigator)
2017 NIHR RfPB Programme: Can treatment with beta adrenoreceptor blocking drugs reduce the risk of developing symptomatic osteoarthritis and requiring total joint replacement in the general population: a prospective cohort study using data from the UK Clinical Practice Research Datalink. £145,541, NIHR Reference: PB-PG-0816-20025
2017 Dr. Pensee Wu. Pre-eclampsia and long-term cardio-metabolic outcomes. £177,736, Reference: TRF-2017-10-005.
2017 NIHR HSDR program. QualDash: Designing and evaluating an interactive dashboard to improve quality of care. £878,871
2016 Terumo Inc. Complications following PCI; insights from a national dataset. £60,000.00
2016 Arthritis Research Council. Getting sustainable, person-centred musculoskeletal health intelligence from primary care electronic health record linkage and modelling: the PRELIM initiative. £297,834 (Co Investigator)
2016 NIHR School for Primary Care Research Funding Round 12. Quantifying severity of chronic conditions in English Primary Care using the Clinical Practice Research Datalink. £319,861
2016 North Staffordshire Medical Institute. Major bleeding complications following acute myocardial infarction, site, frequency and impact; insight from a national and primary care perspective. £250,000 (Principle Investigator)
2016 Heart Committee North Staffordshire. PCI outcomes in ACS stratified by comorbidity. £100,000 over 3 years commencing 2016 (Principal Investigator)
2016 Daiichi Sankyo. Antiplatelet choice and PCI outcomes, a linked data study. £60,000 commencing 2016 over 1 year (Principal Investigator)
2014 The Health e-Research Centre PhD studentship. Longitudinal changes in mortality following PCI. £60,000 commencing 2014 over 1 year (Principal Investigator)
2014 The Health e-Research Centre PhD studentship. Complications following TAVI; a HES linked study. £60,000 commencing 2014 over 1 year (Principal Investigator)
2014 HOMAGE FP7 European union grant. £350,000 as part of a consortium for £8,000,000 (Principal Investigator)
2012 BIOSENSORS. An engineering analysis into longitudinal stent deformation. £60,000 (Principal Investigator)
2012 Abbott. Computational modelling of longitudinal stent deformation; a mechanistic insight. £60,000.00 (Principal Investigator)
2011 Medtronic.Pacing Induced Cardiomyopathy. £125,000 (Principal Investigator)
2011 CLARHC. A study of exercise adherence of south east asian patients with heart failure. £22,000
2010 George Lancaster award. Targeted metabolomics analysis of adverse cardiac remodelling following myocardial infarction; a first step towards a systems pathology approach. £45,000 (Principal Investigator)
2010 CLARHC. Evaluating outcomes of a cohort of inpatients admitted with suspected non-ST elevation acute coronary syndromes to 4 District General Hospitals in relation to adherence to treatment guidelines. £35,000
2010 BRC. Metabolomic analysis of myocardial infarction and reperfusion; a first step towards a novel insight into metabolic processes underlying arrhythmogenesis. £75,000 (Principal Investigator)
2009 Johnson & Johnson. A metabolomic analysis of adverse cardiac remodelling following myocardial infarction; a first step towards identification of a clinical biomarker £59,872 (Principal Investigator)
2009 CLARHC Physical activity adherence in patients with heart failure. £56,689